1. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., et al. (2006). Cancer statistics, 2006. CA: A Cancer Journal for Clinicians, 56(2), 106–130, Mar–Apr.
2. Anderson, J. D., Hansen, T. P., Lenkowski, P. W., Walls, A. M., Choudhury, I. M., Schenck, H. A., et al. (2003). Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3. Molecular Cancer Therapeutics, 2(11), 1149–1154, Nov.
3. Laniado, M. E., Fraser, S. P., & Djamgoz, M. B. (2001). Voltage-gated K(+) channel activity in human prostate cancer cell lines of markedly different metastatic potential: Distinguishing characteristics of PC-3 and LNCaP cells. Prostate, 46(4), 262–274, Mar 1.
4. Preussat, K., Beetz, C., Schrey, M., Kraft, R., Wolfl, S., Kalff, R., et al. (2003). Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci Letters, 346(1–2), 33–36, Jul 31.
5. Wang, X. T., Nagaba, Y., Cross, H. S., Wrba, F., Zhang, L., & Guggino, S. E. (2000). The mRNA of L-type calcium channel elevated in colon cancer: Protein distribution in normal and cancerous colon. American Journal of Pathology, 157(5), 1549–1562, Nov.